These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31101225)

  • 1. Effect of sacubitril/valsartan on cardiac filling pressures in patients with heart failure: Suggestions for statistical analysis.
    Okutucu S; Bursa N
    Int J Cardiol; 2019 Aug; 288():117. PubMed ID: 31101225
    [No Abstract]   [Full Text] [Related]  

  • 2. Sacubitril/Valsartan (Entresto) for Heart Failure.
    Cheng J
    Am Fam Physician; 2016 Oct; 94(8):611-612. PubMed ID: 27929235
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
    Solomon SD; McMurray JJV; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; van Veldhuisen DJ; Zannad F; Zile MR; Desai AS; Claggett B; Jhund PS; Boytsov SA; Comin-Colet J; Cleland J; Düngen HD; Goncalvesova E; Katova T; Kerr Saraiva JF; Lelonek M; Merkely B; Senni M; Shah SJ; Zhou J; Rizkala AR; Gong J; Shi VC; Lefkowitz MP;
    N Engl J Med; 2019 Oct; 381(17):1609-1620. PubMed ID: 31475794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ▼ Sacubitril valsartan for heart failure.
    Drug Ther Bull; 2016 Jun; 54(6):66-9. PubMed ID: 27284124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into implementation of sacubitril/valsartan into clinical practice.
    Martens P; Beliën H; Dupont M; Mullens W
    ESC Heart Fail; 2018 Jun; 5(3):275-283. PubMed ID: 29464879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF.
    Böhm M; Young R; Jhund PS; Solomon SD; Gong J; Lefkowitz MP; Rizkala AR; Rouleau JL; Shi VC; Swedberg K; Zile MR; Packer M; McMurray JJV
    Eur Heart J; 2017 Apr; 38(15):1132-1143. PubMed ID: 28158398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial.
    Vardeny O; Claggett B; Packer M; Zile MR; Rouleau J; Swedberg K; Teerlink JR; Desai AS; Lefkowitz M; Shi V; McMurray JJ; Solomon SD;
    Eur J Heart Fail; 2016 Oct; 18(10):1228-1234. PubMed ID: 27283779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
    Hubers SA; Brown NJ
    Circulation; 2016 Mar; 133(11):1115-24. PubMed ID: 26976916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF).
    Januzzi JL; Butler J; Fombu E; Maisel A; McCague K; Piña IL; Prescott MF; Riebman JB; Solomon S
    Am Heart J; 2018 May; 199():130-136. PubMed ID: 29754651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF.
    Vaduganathan M; Claggett BL; Desai AS; Anker SD; Perrone SV; Janssens S; Milicic D; Arango JL; Packer M; Shi VC; Lefkowitz MP; McMurray JJV; Solomon SD
    J Am Coll Cardiol; 2020 Jan; 75(3):245-254. PubMed ID: 31726194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sacubitril/valsartan on cardiac filling pressures in patients with left ventricular systolic dysfunction.
    Khan Z; Gholkar G; Tolia S; Kado H; Zughaib M
    Int J Cardiol; 2018 Nov; 271():169-173. PubMed ID: 30093137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalation.
    Chang HY; Feng AN; Fong MC; Hsueh CW; Lai WT; Huang KC; Chong E; Chen CN; Chang HC; Yin WH
    J Cardiol; 2019 Oct; 74(4):372-380. PubMed ID: 30982680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical considerations on the introduction of sacubitril/valsartan in clinical practice: Current evidence and early experience.
    Farmakis D; Bistola V; Karavidas A; Parissis J
    Int J Cardiol; 2016 Nov; 223():781-784. PubMed ID: 27573608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sacubitril/valsartan therapeutic strategy in HFpEF: Clinical insights and perspectives.
    Gori M; D'Elia E; Senni M
    Int J Cardiol; 2019 Apr; 281():158-165. PubMed ID: 30420146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sacubitril-valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO-SAS study design.
    Jaffuel D; Molinari N; Berdague P; Pathak A; Galinier M; Dupuis M; Ricci JE; Mallet JP; Bourdin A; Roubille F
    ESC Heart Fail; 2018 Jun; 5(3):222-230. PubMed ID: 29469206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study.
    Senni M; McMurray JJV; Wachter R; McIntyre HF; Anand IS; Duino V; Sarkar A; Shi V; Charney A
    Eur J Heart Fail; 2018 Mar; 20(3):491-500. PubMed ID: 29164797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.
    Mogensen UM; Køber L; Kristensen SL; Jhund PS; Gong J; Lefkowitz MP; Rizkala AR; Rouleau JL; Shi VC; Swedberg K; Zile MR; Solomon SD; Packer M; McMurray JJV;
    Am Heart J; 2017 Jun; 188():35-41. PubMed ID: 28577679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction Between Sacubitril and Valsartan in Preventing Heart Failure Induced by Aortic Valve Insufficiency in Rats.
    Maslov MY; Foianini S; Mayer D; Orlov MV; Lovich MA
    J Card Fail; 2019 Nov; 25(11):921-931. PubMed ID: 31539619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study.
    Wachter R; Senni M; Belohlavek J; Straburzynska-Migaj E; Witte KK; Kobalava Z; Fonseca C; Goncalvesova E; Cavusoglu Y; Fernandez A; Chaaban S; Bøhmer E; Pouleur AC; Mueller C; Tribouilloy C; Lonn E; A L Buraiki J; Gniot J; Mozheiko M; Lelonek M; Noè A; Schwende H; Bao W; Butylin D; Pascual-Figal D;
    Eur J Heart Fail; 2019 Aug; 21(8):998-1007. PubMed ID: 31134724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacubitril + valsartan (Entresto°) in chronic heart failure.
    Prescrire Int; 2017 Feb; 26(179):33-37. PubMed ID: 30726626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.